Chronic News and Research

RSS

University Hospital Bonn to validate accuracy of VolitionRx’s Nucleosomics technology in lung cancer

VolitionRx Limited, a life sciences company focused on developing diagnostic tests for cancer and other conditions, today announced that the University Hospital Bonn in Germany will initiate a clinical confirmatory study to assess VolitionRx’s proprietary Nucleosomics platform technology for the diagnosis of lung cancer through a blood test in individuals.

18 Dec 2014

EC grants orphan drug designation to TxCell's Col-Treg for treatment of autoimmune uveitis

TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that the European Commission (EC) has granted orphan drug designation to TxCell's investigational medicinal product Col-Treg, a personalized T cell immunotherapy using collagen-II specific regulatory T-cells, for the treatment of autoimmune uveitis.

18 Dec 2014

Insomnia is a marker for increased risk of back pain, say University of Haifa researchers

Having trouble sleeping? Then you are nearly one-and-a-half times more likely to eventually suffer from back pain, according to a new study conducted by the University of Haifa.

17 Dec 2014

Joslin study could lead to improved anti-aging drugs

In a study published today by Nature, researchers at Joslin Diabetes Center used a microscopic worm (C. elegans) to identify a new path that could lead to drugs to slow aging and the chronic diseases that often accompany it--and might even lead to better cosmetics.

16 Dec 2014

Landmark GRACE study helps shape the practice of geriatric medicine

The seminal 2007 GRACE study from the Indiana University Center for Aging Research and the Regenstrief Institute has been identified as one of 27 studies conducted over the past quarter century that have helped shape the practice of geriatric medicine. The GRACE study involved community-dwelling seniors and their primary-care physicians in a team approach to optimize health and decrease cost of care.

16 Dec 2014

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech company developing novel treatments for chronic diseases, investigators also observed improvements in metabolic control in patients administered ARA 290.

16 Dec 2014

Sophia Genetics earns ISO 13485 and ISO 27001 certification for safe data handling and security

Sophia Genetics, the European leader in Clinical Genomics and Next Generation DNA Sequencing (NGS), has become the first company to achieve both ISO 13485 and ISO 27001 certification for its commitment to safe data handling and security.

16 Dec 2014

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

A team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park Cancer Institute has reported new findings regarding therapeutic targets of the novel anticancer agent FL118. Previous studies from these researchers have showed that FL118 induces cancer cell death, or apoptosis, by inhibiting expression of multiple cell-survival proteins (survivin, Mcl-1, XIAP or cIAP2).

15 Dec 2014

Heroin use impacts HIV disease progression

Researchers at Yale and Boston University and their Russian collaborators have found that occasional heroin use by HIV-positive patients may be particularly harmful to the immune system and worsens HIV disease, compared to persistent or no heroin use.

15 Dec 2014

Revolutionising back pain treatments: an interview with Dr Kieran O’Sullivan

Back pain is exceptionally common. In fact, to not experience back pain at some point of your life would be thoroughly abnormal. Experiencing back pain is like becoming tired or becoming sad; we don’t necessarily like it, but it’s perfectly common.

14 Dec 2014

Crealta publishes review of post-hoc safety analysis completed for Krystexxa

Crealta Pharmaceuticals LLC, today announced that the Journal of Clinical Rheumatology published a comprehensive review of a post-hoc safety analysis that was completed for Krystexxa (pegloticase), including data from the two pivotal randomized Phase III trials and one open-label extension trial.

14 Dec 2014

Study: Patients with operable kidney cancers more likely to have partial nephrectomy

Patients with operable kidney cancers were more likely to have a partial nephrectomy -- the recommended treatment for localized tumors -- when treated in hospitals that were early adopters of robotic surgery, according to a new study.

14 Dec 2014

HEPscreen Toolkit seeks to raise awareness on chronic viral hepatitis in Europe

A new toolkit on screening for chronic viral hepatitis seeks to raise awareness, improve knowledge and motivate public health professionals in Europe to take action. Knowledge and understanding of what works in screening for chronic hepatitis B/C has now been translated into practical and relevant tools, including videos and animations, to enable others to replicate successful screening programmes among at risk populations in their area.

14 Dec 2014

New study eliminates hepatitis C virus as causative factor of mental impairment in HIV patients

Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer. As they age, however, many experience impaired thinking, memory loss, mood swings and other evidence of impaired mental function.

14 Dec 2014

New study helps identify public health needs relating to HIV/AIDS, hepatitis C in Massachusetts

A new study from epidemiologists at Tufts University School of Medicine helps to identify communities with the greatest public health need in Massachusetts for resources relating to HIV/AIDS and hepatitis C.

14 Dec 2014

Many college students regard hookah smoking safer than smoking cigarettes

Despite emerging evidence otherwise, many college students consider hookah smoking safer than smoking cigarettes, reports a University of South Florida College of Public Health study published this month by the Centers for Disease Control and Prevention.

14 Dec 2014

Penn researchers find effective way to inhibit inflammatory response during kidney dialysis

Frequent kidney dialysis is essential for the approximately 350,000 end-stage renal disease (ESRD) patients in the United States. But it can also cause systemic inflammation, leading to complications such as cardiovascular disease and anemia, and patients who rely on the therapy have a five-year survival rate of only 35 percent. Such inflammation can be triggered when the complement cascade, part of the body's innate immune system, is inadvertently activated by modern polymer-based dialysis blood filters.

14 Dec 2014

GHC, DSM highlight the growing issue of micronutrient deficiency in the U.S.

Global Health Corps and DSM called attention to the growing issue of micronutrient deficiency in the U.S. in a press conference with Barbara Bush, CEO of GHC, Hugh Welsh, President of DSM North America, Newark Municipal Council President Mildred Crump and Jim White, Executive Director of Covenant House New Jersey.

14 Dec 2014

Boston Scientific Precision Spectra SCS System provides sustained relief for low back pain patients

New retrospective data evaluating the Boston Scientific Corporation Precision Spectra Spinal Cord Stimulator (SCS) System demonstrate that the device provided sustained, highly significant relief of low back pain 12 months after implantation.

14 Dec 2014

Livongo Health, Iron Mountain collaborate to improve health of their employees with diabetes

Livongo Health, a consumer digital health company that is focused on using technology to empower people with chronic conditions to live better, today announced an agreement with Iron Mountain Incorporated. They wanted to improve the health and productivity of their employees with diabetes while reducing the cost of care.

14 Dec 2014

Chronic News and Research

University Hospital Bonn to validate accuracy of VolitionRx’s Nucleosomics technology in lung cancer

EC grants orphan drug designation to TxCell's Col-Treg for treatment of autoimmune uveitis

Insomnia is a marker for increased risk of back pain, say University of Haifa researchers

Joslin study could lead to improved anti-aging drugs

Landmark GRACE study helps shape the practice of geriatric medicine

ARA 290 drug reduces neuropathic pain in type 2 diabetic patients

Sophia Genetics earns ISO 13485 and ISO 27001 certification for safe data handling and security

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

Heroin use impacts HIV disease progression

Revolutionising back pain treatments: an interview with Dr Kieran O’Sullivan

Crealta publishes review of post-hoc safety analysis completed for Krystexxa

Study: Patients with operable kidney cancers more likely to have partial nephrectomy

HEPscreen Toolkit seeks to raise awareness on chronic viral hepatitis in Europe

New study eliminates hepatitis C virus as causative factor of mental impairment in HIV patients

New study helps identify public health needs relating to HIV/AIDS, hepatitis C in Massachusetts

Many college students regard hookah smoking safer than smoking cigarettes

Penn researchers find effective way to inhibit inflammatory response during kidney dialysis

GHC, DSM highlight the growing issue of micronutrient deficiency in the U.S.

Boston Scientific Precision Spectra SCS System provides sustained relief for low back pain patients

Livongo Health, Iron Mountain collaborate to improve health of their employees with diabetes

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News